Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib effectively regrows hair in adolescents with alopecia areata and is safe.

The Ar/miR-221/IGF-1 pathway is involved in male pattern baldness, with miR-221 potentially being a new target for treatment.

Baricitinib is effective and safe for long-term use in severe alopecia areata, improving hair regrowth and quality of life with few side effects.

Skin-resident memory T cells may contribute to chronic alopecia areata and baricitinib could be a potential treatment.

Mouse models help understand alopecia areata and find treatments.

A woman with alopecia regrew her hair after taking a higher dose of tocilizumab.

Long-term data and a team approach are needed to manage chronic side effects from cancer treatments.

Aloe vera extract speeds up and improves wound healing in rabbits.

Tofacitinib helped improve symptoms and hair growth in a patient with Aicardi-Goutières syndrome.

Androgenetic alopecia is a condition causing noticeable hair loss, especially in middle age, which is more severe than normal balding.

Interleukin-15 can help hair growth and protect hair follicles.

Upadacitinib significantly improved alopecia universalis and psoriatic arthritis in a patient.

The Free Androgen Index (FAI) is the best indicator of early hair loss in men before age 30.

A patient with Alopecia Areata had complete hair regrowth after using the drug baricitinib.

ILC1-like cells may contribute to hair loss in alopecia areata and could be new treatment targets.

Avicennia marina extract can significantly promote hair growth in androgenic alopecia patients.

IMG-007 helps regrow hair and reduce scalp inflammation in severe alopecia areata.

An AI photographic device effectively tracked hair growth improvements in women treated for hair loss.

Treatment type and patch size affect hair regrowth patterns in alopecia areata.

Ritlecitinib is cost-effective for severe alopecia areata in Japan.

Some medications for inflammation can cause a condition with scalp rashes and hair loss, often linked to Crohn's disease, and may require treatment changes to prevent permanent hair loss.

The conclusion is that a treatment called cp-asiAR can reduce hair loss and promote hair growth, making it a potential new therapy for androgenetic alopecia.

The role of γδT-cells in causing alopecia areata remains unclear.

Both induced and spontaneous AA lymphocytes can cause alopecia areata in mice.

Phospholipids help plant proteins move by regulating receptor interactions.

N‐AOHPA is a promising alternative to traditional surfactants for better hair conditioning.

Traumatic stress and alexithymia may contribute to alopecia areata.

Alopecia areata is a common autoimmune condition causing varying hair loss, diagnosed by specific patterns of inflammation around hair follicles, with several treatment options available.

Intramuscular triamcinolone and pulse therapy with oral predonine are effective for alopecia areata with manageable side effects, but better relapse prevention is needed.